June 11, 2019 11:41 AM EDT
News Briefing

Nas­daq delists In­sys af­ter bank­rupt­cy fil­ing; Chi­na's Zai Lab li­cens­es sol­id tu­mor drug from De­ci­phera

Kathy Wong

Editor

→ On the heels of a bank­rupt­cy fil­ing, In­sys an­nounced that it’s get­ting delist­ed from the Nas­daq. Trad­ing of the stock …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Ex­clu­sive: A small biotech will bring Roche's An­gel­man drug back to life

Sanofi’s Kymab-orig­i­nat­ed in­flam­ma­to­ry drug flunks mid-stage asth­ma tri­al

Sid­dhartha Mukher­jee’s cell ther­a­py start­up nar­rows fo­cus as staff shrinks

Mer­ck ex­plores po­ten­tial of oral pep­tides in deal with Aus­tri­an biotech

Mur­al On­col­o­gy ends clin­i­cal de­vel­op­ment, lays off most work­ers

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times